from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2251/-

LFCtreatmentdescriptionclass of inhibitor

-0.181

Amikacinug/mL Amikacintranslation

-0.871

Cap5-10ug/mL Capreomycintranslation

-0.431

Rox10-50 ug/mL Roxithromycintranslation

-0.049

SM2-5 ug/mL Streptomycintranslation

0.671

Tet5-10 ug/mL Tetracyclinetranslation

-0.668

Rif0.2-5ug/mL Rifampicintranscription

-0.396

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.394

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.137

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.176

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.288

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.102

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.184

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.024

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.952

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.435

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.112

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.112

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.044

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.708

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.235

KCN5-20 ug/mL Potassium cyaniderespiration

0.325

NaN30.2-2 mM Sodium aziderespiration

-0.260

Nigericin50 uM Nigericinrespiration

0.243

TRC10-150 ug/mL Triclosanrespiration

0.343

TRZ10-25 ug/mL Thioridazinerespiration

0.597

Valinomycin0.5-10 uM Valinomycinrespiration

-0.822

ZnSO42 mM ZnSO4respiration

0.987

menadione6-10 ug/mL Menadionerespiration

0.411

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.568

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.695

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.573

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.344

NRP_1Non-replicating persistence stage 1dosRassociated

-0.889

Amp0.2mg/mL AmpicillincellWall

0.243

Cephalexin20-100 ug/mL CephalexincellWall

0.117

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.564

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.180

EMB10-20 ug/mL EthambutolcellWall

0.350

Eta12-40 ug/mL EthionamidecellWall

0.235

INH0.2-0.4 ug/mL IsoniazidcellWall

0.011

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.060

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.082

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.693

BZA0.12 mg/mL BenzamidearomaticAmides

-0.512

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.164

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.594

H2O24 mM hydrogen peroxideDNAdamaging

-0.658

Levo10 ug/mL LevofloxacinDNAdamaging

-0.916

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.213

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.208

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.495

UVUV-irradiationDNAdamaging

6.029

ARP41-4 ug/mL Antitubercular compound ARP4?

0.472

Antimycin12.5-50 ug/mL Antimycin A?

-0.271

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.130

PA_110-50 ug/mL Antitubercular compound PA-1?

0.403

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.363

PA8240.2-2 ug/mL PA-824?

0.871

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.502

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.276

Verapamil50 uM Verapamil?

0.325

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.437

methoxatin10-20 ug/mL Methoxatin?